92 related articles for article (PubMed ID: 34459134)
1. Liquid Biopsies as Non-Invasive Tools for Mutation Profiling in Multiple Myeloma: Application Potential, Challenges, and Opportunities.
Heestermans R; Schots R; De Becker A; Van Riet I
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791247
[TBL] [Abstract][Full Text] [Related]
2. Hydrogel-based technologies in liquid biopsy for the detection of circulating clinical markers: challenges and prospects.
Kim YJ; Min J
Anal Bioanal Chem; 2024 Apr; 416(9):2065-2078. PubMed ID: 37963993
[TBL] [Abstract][Full Text] [Related]
3. Circulating Tumor DNA Dynamics: A New Approach in Revolutionizing Cancer Management.
Surendran AK; Mavani PT; Vijayakumar C
Ann Surg Oncol; 2024 Jan; 31(1):163-164. PubMed ID: 37838647
[No Abstract] [Full Text] [Related]
4. Leveraging archival cerebrospinal fluid samples for genetic insights from cell-free DNA.
Miller AM; Bale TA
Cancer Cytopathol; 2024 Apr; 132(4):212-213. PubMed ID: 38427323
[No Abstract] [Full Text] [Related]
5. Programmed Death 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 Gene Expression in Peripheral Blood Mononuclear Cells Can Serve as Prognostic Biomarkers for Hepatocellular Carcinoma.
Lee JA; Choi HG; Eun HS; Bu J; Jang TM; Lee J; Son CY; Kim MS; Rou WS; Kim SH; Lee BS; Kim HN; Lee TH; Jeon HJ
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672574
[TBL] [Abstract][Full Text] [Related]
6. The coming of age of liquid biopsy in neuro-oncology.
Berzero G; Pieri V; Mortini P; Filippi M; Finocchiaro G
Brain; 2023 Oct; 146(10):4015-4024. PubMed ID: 37289981
[TBL] [Abstract][Full Text] [Related]
7. Circulating Tumor Cells as Biomarkers for Renal Cell Carcinoma: Ready for Prime Time?
Couto-Cunha A; Jerónimo C; Henrique R
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612281
[TBL] [Abstract][Full Text] [Related]
8. Exosome Structures Supported by Machine Learning Can Be Used as a Promising Diagnostic Tool.
Cansever Mutlu E; Kaya M; Küçük I; Ben-Nissan B; Stamboulis A
Materials (Basel); 2022 Nov; 15(22):. PubMed ID: 36431454
[TBL] [Abstract][Full Text] [Related]
9. The Promise of Circulating Tumor DNA in Head and Neck Cancer.
Aulakh SS; Silverman DA; Young K; Dennis SK; Birkeland AC
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740633
[TBL] [Abstract][Full Text] [Related]
10. Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC).
Lee T; Rawding PA; Bu J; Hyun S; Rou W; Jeon H; Kim S; Lee B; Kubiatowicz LJ; Kim D; Hong S; Eun H
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565192
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of CSTB and DMBT1 expression in saliva of gastric cancer patients and controls.
Koopaie M; Ghafourian M; Manifar S; Younespour S; Davoudi M; Kolahdooz S; Shirkhoda M
BMC Cancer; 2022 Apr; 22(1):473. PubMed ID: 35488257
[TBL] [Abstract][Full Text] [Related]
12. Cytochalasin B Treatment and Osmotic Pressure Enhance the Production of Extracellular Vesicles (EVs) with Improved Drug Loading Capacity.
Nair A; Bu J; Rawding PA; Do SC; Li H; Hong S
Nanomaterials (Basel); 2021 Dec; 12(1):. PubMed ID: 35009953
[TBL] [Abstract][Full Text] [Related]
13. Fabrication of Formalin-Fixed, Paraffin-Embedded (FFPE) Circulating Tumor Cell (CTC) Block Using a Hydrogel Core-Mediated Method.
Lee TH; Kim YJ; Rou WS; Eun HS
Micromachines (Basel); 2021 Sep; 12(9):. PubMed ID: 34577771
[TBL] [Abstract][Full Text] [Related]
14. Tri-modal liquid biopsy: Combinational analysis of circulating tumor cells, exosomes, and cell-free DNA using machine learning algorithm.
Bu J; Lee TH; Poellmann MJ; Rawding PA; Jeong WJ; Hong RS; Hyun SH; Eun HS; Hong S
Clin Transl Med; 2021 Aug; 11(8):e499. PubMed ID: 34459134
[No Abstract] [Full Text] [Related]
15. Potential of circulating biomarkers in liquid biopsy diagnostics.
Yeo JC; Lim CT
Biotechniques; 2018 Oct; 65(4):187-189. PubMed ID: 30284936
[No Abstract] [Full Text] [Related]
16. Liquid biopsy in breast cancer: A comprehensive review.
Alimirzaie S; Bagherzadeh M; Akbari MR
Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy in ovarian cancer.
Giannopoulou L; Lianidou ES
Adv Clin Chem; 2020; 97():13-71. PubMed ID: 32448432
[TBL] [Abstract][Full Text] [Related]
18. Liquid Biopsy in Bladder Cancer.
Cui Y; Cao M
Methods Mol Biol; 2023; 2695():111-120. PubMed ID: 37450114
[TBL] [Abstract][Full Text] [Related]
19. Liquid Biopsy: A New Tool in Oncology.
Costa JL; Schmitt FC
Acta Cytol; 2019; 63(6):448. PubMed ID: 31266005
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
